Evidence map›Paper›PMID 42260109›Full record

ArticleLeukemia2026

Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

A Piciocchi, A Talone, M Messina, P de Fabritiis, G Marsili, V Sargentini, S Soddu, L Cicconi, L Guarnera, M D Divona and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

A PiciocchiGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy. a.piciocchi@gimema.it.ORCID http://orcid.org/0000-0001-8648-885X
A TaloneGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
M MessinaGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
P de FabritiisGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
G MarsiliGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
V SargentiniGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
S SodduGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.ORCID http://orcid.org/0000-0002-1942-1230
L CicconiDepartment of Hematology, Santa Maria Goretti Hospital, Polo Universitario Pontino, Latina, Italy.
L GuarneraHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0001-8293-0663
M D DivonaHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
P MustoUnit of Hematology and Stem Cell Transplantation, AOUC Policlinico and Department of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.ORCID http://orcid.org/0000-0003-3277-6594
F FerraraEmatologia, AORN A. Cardarelli, Napoli, Italy.
S D'ArdiaSC Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
E BorlenghiSC di Ematologia, ASST Spedali Civili, Brescia, Italy.
F BuccisanoHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
M BrecciaHematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy.ORCID http://orcid.org/0000-0003-1163-6162
F EfficaceGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.ORCID http://orcid.org/0000-0002-5065-5166
P FaziGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.
A VendittiHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0002-0245-0553
F Lo CocoHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
U PlatzbeckerDepartment of Hematology, Oncology and Stem cell Transplantation, University Hospital, Leipzig, Germany.
M VignettiGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Foundation, Rome, Italy.ORCID http://orcid.org/0000-0003-1278-604X
M T VosoHematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0002-6164-4761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42260109
PMCPMC13322965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.